TrialCardiovascular drugs and therapy2023

Rivaroxaban After Transcatheter Aortic Valve Replacement: A Critical Appraisal of the GALILEO Trial.

Patrick Sulzgruber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.